Dentsply Sirona announced the appointment of David Ferguson as senior vice president and global business unit leader, effective March 14, 2025. In this role, Ferguson will oversee the global business unit teams managing the company’s dental product portfolio, serve as a member of the executive management team, and report directly to CEO Simon Campion.
Ferguson’s appointment follows his 25 years of experience in the med tech and healthcare sectors. He has a proven track record in delivering results, competing in global markets, and leading product strategy. Prior to joining Dentsply Sirona, Ferguson held leadership positions at companies including GE Healthcare, Baxter, and Philips.
Simon Campion, president and CEO of Dentsply Sirona, expressed his enthusiasm about the appointment: “We are delighted to welcome David as our new global business unit leader. With his experience in developing and executing strategic growth plans, as well as building and aligning high-performing teams, he brings invaluable expertise to our organization. His deep business acumen will be key to driving improved business performance and capitalizing on strategic opportunities that exist with our broad and differentiated portfolio. We are confident that David’s leadership will further strengthen our position in the market.”
Ferguson shared his thoughts on the new role: “I’m excited to join Dentsply Sirona and contribute to shaping the next chapter alongside an incredible global team. With its broad-based portfolio, Dentsply Sirona is well positioned to capitalize on the evolving competitive landscape. I look forward to collaborating with the team to enhance execution, drive financial, operational, and strategic goals, and profitable growth.”
Ferguson’s career includes leadership roles at several well-known companies in the healthcare sector. Most recently, he served as president of Gore Medical, a unit of W.L. Gore. Previously, Ferguson was executive vice president at Philips and president & CEO of Philips Respironics, where he managed a global team of 6,000 people. At Baxter Healthcare, he led the global infusion therapy, IV solutions, and patient monitoring business. Ferguson has also held leadership roles at GE Healthcare.
Ferguson holds a PhD in chemistry from Texas A&M University, a bachelor of science in biochemistry from David Lipscomb University, and graduated from the Advanced Management Program at the University of Chicago Booth School of Business. He has served on multiple boards, including AZBio, Philips PAC, and Baxter International Foundation. Ferguson is also a co-inventor of two U.S. patents and the author of ten peer-reviewed publications.
Figures and Images
